Houston, Remote Work (USA) Remote (Global) Full-time $220,000 - $270,000

Immatics is hiring a Director, Medical Communications

About the Role

As Director, Medical Communications, you will lead the strategic development and execution of global scientific dissemination for a breakthrough adoptive cell therapy. You will own the end-to-end delivery of high-impact publications and congress materials, aligning timelines with clinical milestones and launch readiness. Your leadership will ensure scientific consistency, compliance, and clarity across all external communications.

Strategic Leadership & Scientific Dissemination

You will direct the global publication planning process, maintaining a dynamic 12–24 month calendar that synchronizes data availability, internal governance, and external submission deadlines. You will define authorship strategy for key journals and congresses, ensuring competitive positioning and scientific differentiation. This includes managing complex data outputs—such as post hoc analyses and collaborative translational research—and guiding their ethical, compliant disclosure.

You will lead congress strategy for major oncology meetings, developing data narratives, coordinating internal reviews, and planning post-event dissemination. Your work will directly support market adoption by translating emerging evidence into compelling, non-promotional scientific content for clinicians and researchers.

Scientific Platform & Message Governance

You will develop and maintain a centralized Scientific Platform & Lexicon, establishing core terminology, claims standards, and data interpretation guidelines. This framework will ensure message consistency across publications, advisory boards, training materials, and medical communications. You will implement a structured refresh cycle tied to data readouts and governance decisions, with full traceability to source evidence.

You will embed this platform into all communication outputs and ensure its adoption across Medical Affairs and cross-functional teams. This includes designing and delivering training on narrative development, publication ethics, and compliant disclosure practices.

Insight Generation & Cross-Functional Collaboration

You will operationalize an insight engine across advisory boards, data reviews, and congress debriefs. By designing standardized capture tools and taxonomies, you will synthesize stakeholder feedback into actionable intelligence for medical and commercial strategy. You will communicate emerging themes, risks, and opportunities to internal teams to inform evidence planning and lifecycle strategy.

Operations & Vendor Management

You will lead vendor partners in publication and congress execution, managing scopes, timelines, quality standards, and performance metrics. You will steward budgets, conduct quarterly reviews, and drive process improvements to enhance efficiency and compliance. You will also develop scalable templates, checklists, and SOPs to strengthen publication operations across the organization.

Compliance & Training

You will ensure all communications adhere to ICMJE and GPP standards, including authorship, conflict of interest, and data transparency. You will maintain audit-ready documentation and lead training initiatives for internal stakeholders on publication processes, scientific narrative discipline, and lifecycle messaging. Your guidance will support Medical Affairs teams from pre-launch through post-launch data evolution.

Qualifications

  • Advanced scientific or medical degree (MD, PharmD, PhD, or APN) required
  • 10+ years in Medical Communications or Publications within biotech/pharma or agency settings
  • Proven leadership in global publication planning and major oncology congress execution
  • Experience building and governing scientific platforms across global teams
  • Strong background in compliant scientific writing, data interpretation, and cross-functional collaboration
  • Track record in insight generation from advisory boards, KOL engagement, and congress debriefs
  • Experience developing and delivering scientific training for Medical Affairs and commercial partners
  • Vendor management expertise in scope, budget, quality, and performance

Preferred Experience

  • Background in TCR, CAR T, or other adoptive cell therapies
  • Experience with nontraditional datasets (e.g., compassionate use, translational collaborations)
  • Support for market access submissions (e.g., NCCN, CMS NTAP, ICER, AMCP, GVD)

Compensation & Benefits

This role offers a base salary range of $220,000 – $270,000. The position is fully remote with no location restrictions. Benefits include comprehensive health, dental, and vision insurance; 4 weeks of paid time off granted upfront; 56 hours of sick time; and 12 paid holidays. Life insurance is fully employer-paid up to 1x annual salary.

Work Environment

You will work in a collaborative, innovative setting focused on advancing cancer immunotherapy. The team values scientific rigor, professional growth, and global patient impact. Employment decisions are based on merit, competence, and business needs, without regard to race, color, religion, national origin, gender, sexual orientation, disability, veteran status, or other protected categories.

Required Skills
Medical CommunicationsGlobal Publication PlanningScientific Narrative DevelopmentCross-Functional LeadershipOncologyCancer ImmunotherapyClinical DevelopmentScientific Platform GovernancePRAME TargetingPharmaceutical Launch Readiness Medical CommunicationsGlobal Publication PlanningScientific Narrative DevelopmentCross-Functional LeadershipOncologyCancer ImmunotherapyClinical DevelopmentScientific Platform GovernancePRAME TargetingPharmaceutical Launch Readiness
Looking for a remote dev community?

200+ professionals, 37 countries, one network

Working remotely doesn't mean working alone. Iglu connects you with developers, designers, and digital experts worldwide. Collaborate, learn, and grow together.

Global professional network
Knowledge sharing & collaboration
Regular community events
Cross-project opportunities
Join the community
37 countries represented
About company
Immatics

Immatics combines the discovery of cancer targets with T cell receptor development to create Adoptive Cell Therapies and TCR Bispecifics.

PRAME is a target expressed in more than 50 cancers, including melanoma, lung, ovarian, breast, and endometrial cancer, among many others. Targeting PRAME unlocks new treatment options for a broad patient population with significant unmet medical need.

The company is advancing targeted PRAME cell therapies and bispecific product candidates through clinical trials, aiming to bring innovative cancer treatments from lab to clinic.

All jobs at Immatics Visit website
Job Details
Category management
Posted 21 days ago